# EDGAR Filing Document

**Accession Number:** 0001665650
**File Stem:** 0001213900-23-015483
**Filing Date:** 2023-2
**Character Count:** 99079
**Document Hash:** 509a50657f9df479dde0cc403ca53c56
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-015483.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001213900-23-015483

**CONFORMED SUBMISSION TYPE**: 424B2

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-236659
- **FILM NUMBER:** 23686289

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMorgan Chase Financial Co. LLC
- **CENTRAL INDEX KEY:** 0001665650
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 475462128
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-236659-01
- **FILM NUMBER:** 23686290

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** (212) 270-6000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179

---

| | |
|:---|:---|
| **JPMorgan Chase Financial Company LLC** | **February 2023** |
|  | Pricing Supplement |
|  | Registration Statement Nos. 333-236659 and 333-236659-01 |
|  | Dated February 24, 2023 |
|  | Filed pursuant to Rule 424(b)(2) |

---

Structured Investments

Opportunities in U.S. Equities

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index<br> Principal at Risk Securities**

**Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.**

Contingent Income Callable Securities do not guarantee the payment of interest or the repayment of principal. Instead, the securities offer the opportunity for investors to earn a contingent quarterly payment equal to 2.40% of the stated principal amount with respect to each determination date on which the closing level of the underlying index is greater than or equal to 80% of the initial index value, which we refer to as the downside threshold level. However, if, on any determination date, the closing level of the underlying index is less than the downside threshold level, you will not receive any contingent quarterly payment for that quarterly period. In addition, **we will have the right to redeem the securities at our discretion on any contingent payment date** (other than the final contingent payment date) for an early redemption payment equal to the stated principal amount *plus* any contingent quarterly payment with respect to the related determination date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. If the securities have not been redeemed prior to maturity and the final index value is greater than or equal to the downside threshold level, the payment at maturity due on the securities will be the stated principal amount and the contingent quarterly payment with respect to the final determination date. If, however, the securities have not been redeemed prior to maturity and the final index value is less than the downside threshold level, you will be exposed to the decline in the underlying index, as compared to the initial index value, on a 1-to-1 basis and will receive a cash payment at maturity that is less than 80% of the stated principal amount of the securities and could be zero. The securities are for investors who are willing to risk their principal and seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of receiving few or no contingent quarterly payments and also the risk of receiving a cash payment at maturity that is significantly less than the stated principal amount of the securities and could be zero. **Accordingly, investors could lose their entire initial investment in the securities.** Investors will not participate in any appreciation of the underlying index. The securities are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co., issued as part of JPMorgan Financial's Medium-Term Notes, Series A, program. **Any payment on the securities is subject to the credit risk of JPMorgan Financial, as issuer of the securities, and the credit risk of JPMorgan Chase & Co., as guarantor of the securities.**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**FINAL TERMS** | | | |
| &nbsp;&nbsp;**Issuer:** | JPMorgan Chase Financial Company LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase & Co. | JPMorgan Chase Financial Company LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase & Co. | JPMorgan Chase Financial Company LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase & Co. |
| &nbsp;&nbsp;**Guarantor:** | JPMorgan Chase & Co. | JPMorgan Chase & Co. | JPMorgan Chase & Co. |
| &nbsp;&nbsp;**Underlying index:** | S&P 500<sup>®</sup> Index (Bloomberg ticker: SPX Index) | S&P 500<sup>®</sup> Index (Bloomberg ticker: SPX Index) | S&P 500<sup>®</sup> Index (Bloomberg ticker: SPX Index) |
| &nbsp;&nbsp;**Aggregate principal amount:** | $11370000 | $11370000 | $11370000 |
| &nbsp;&nbsp;**Optional early redemption:** | We, **at our discretion**, may redeem the securities early, in whole but not in part, on any of the contingent payment dates (other than the final contingent payment date) for the early redemption payment. If we intend to redeem your securities early, we will deliver notice to The Depository Trust Company, or DTC, at least three business days before the applicable contingent payment date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. No further payments will be made on the securities once they have been redeemed. | We, **at our discretion**, may redeem the securities early, in whole but not in part, on any of the contingent payment dates (other than the final contingent payment date) for the early redemption payment. If we intend to redeem your securities early, we will deliver notice to The Depository Trust Company, or DTC, at least three business days before the applicable contingent payment date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. No further payments will be made on the securities once they have been redeemed. | We, **at our discretion**, may redeem the securities early, in whole but not in part, on any of the contingent payment dates (other than the final contingent payment date) for the early redemption payment. If we intend to redeem your securities early, we will deliver notice to The Depository Trust Company, or DTC, at least three business days before the applicable contingent payment date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. No further payments will be made on the securities once they have been redeemed. |
| &nbsp;&nbsp;**Early redemption payment:** | The early redemption payment will be an amount equal to (i) the stated principal amount *plus* (ii) any contingent quarterly payment with respect to the related determination date. | The early redemption payment will be an amount equal to (i) the stated principal amount *plus* (ii) any contingent quarterly payment with respect to the related determination date. | The early redemption payment will be an amount equal to (i) the stated principal amount *plus* (ii) any contingent quarterly payment with respect to the related determination date. |
| &nbsp;&nbsp;**Contingent quarterly payment:** | · If, on any determination date, the closing level is greater than or equal to the downside threshold level, we will pay a contingent quarterly payment of $24.00 (2.40% of the stated principal amount) per security on the related contingent payment date. <br> · If, on any determination date, the closing level is less than the downside threshold level, no contingent quarterly payment will be made with respect to that determination date. **It is possible that the closing level of the underlying index will be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments**. | · If, on any determination date, the closing level is greater than or equal to the downside threshold level, we will pay a contingent quarterly payment of $24.00 (2.40% of the stated principal amount) per security on the related contingent payment date. <br> · If, on any determination date, the closing level is less than the downside threshold level, no contingent quarterly payment will be made with respect to that determination date. **It is possible that the closing level of the underlying index will be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments**. | · If, on any determination date, the closing level is greater than or equal to the downside threshold level, we will pay a contingent quarterly payment of $24.00 (2.40% of the stated principal amount) per security on the related contingent payment date. <br> · If, on any determination date, the closing level is less than the downside threshold level, no contingent quarterly payment will be made with respect to that determination date. **It is possible that the closing level of the underlying index will be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments**. |
| &nbsp;&nbsp;**Determination dates:** | May 24, 2023, August 24, 2023, November 24, 2023, February 26, 2024, May 24, 2024, August 26, 2024, November 25, 2024 and February 24, 2025, subject to postponement for non-trading days and certain market disruption events | May 24, 2023, August 24, 2023, November 24, 2023, February 26, 2024, May 24, 2024, August 26, 2024, November 25, 2024 and February 24, 2025, subject to postponement for non-trading days and certain market disruption events | May 24, 2023, August 24, 2023, November 24, 2023, February 26, 2024, May 24, 2024, August 26, 2024, November 25, 2024 and February 24, 2025, subject to postponement for non-trading days and certain market disruption events |
| &nbsp;&nbsp;**Contingent payment dates:** | May 30, 2023, August 29, 2023, November 29, 2023, February 29, 2024, May 30, 2024, August 29, 2024, November 29, 2024 and the maturity date, subject to postponement in the event of certain market disruption events and as described under "General Terms of the Notes — Postponement of Payment Date" in the accompanying product supplement | May 30, 2023, August 29, 2023, November 29, 2023, February 29, 2024, May 30, 2024, August 29, 2024, November 29, 2024 and the maturity date, subject to postponement in the event of certain market disruption events and as described under "General Terms of the Notes — Postponement of Payment Date" in the accompanying product supplement | May 30, 2023, August 29, 2023, November 29, 2023, February 29, 2024, May 30, 2024, August 29, 2024, November 29, 2024 and the maturity date, subject to postponement in the event of certain market disruption events and as described under "General Terms of the Notes — Postponement of Payment Date" in the accompanying product supplement |
| &nbsp;&nbsp;**Payment at maturity:** | · If the final index value is **greater than or equal to** the downside threshold level: | &nbsp;&nbsp;(i) the stated principal amount *plus* (ii) the contingent quarterly payment with respect to the final determination date | &nbsp;&nbsp;(i) the stated principal amount *plus* (ii) the contingent quarterly payment with respect to the final determination date |
|  | · If the final index value is **less than** the downside threshold level: | &nbsp;&nbsp;(i) the stated principal amount *times* (ii) the index performance factor. This cash payment will be less than 80% of the stated principal amount of the securities and could be zero. | &nbsp;&nbsp;(i) the stated principal amount *times* (ii) the index performance factor. This cash payment will be less than 80% of the stated principal amount of the securities and could be zero. |
| &nbsp;&nbsp;**Downside threshold level:** | 3,176.032, which is equal to 80% of the initial index value | 3,176.032, which is equal to 80% of the initial index value | 3,176.032, which is equal to 80% of the initial index value |
| &nbsp;&nbsp;**Initial index value:** | 3,970.04, which was the closing level of the underlying index on the pricing date | 3,970.04, which was the closing level of the underlying index on the pricing date | 3,970.04, which was the closing level of the underlying index on the pricing date |
| &nbsp;&nbsp;**Final index value:** | The closing level of the underlying index on the final determination date | The closing level of the underlying index on the final determination date | The closing level of the underlying index on the final determination date |
| &nbsp;&nbsp;**Index performance factor:** | final index value / initial index value | final index value / initial index value | final index value / initial index value |
| &nbsp;&nbsp;**Stated principal amount:** | $1,000 per security | $1,000 per security | $1,000 per security |
| &nbsp;&nbsp;**Issue price:** | $1,000 per security (see "Commissions and issue price" below) | $1,000 per security (see "Commissions and issue price" below) | $1,000 per security (see "Commissions and issue price" below) |
| &nbsp;&nbsp;**Pricing date:** | February 24, 2023 | February 24, 2023 | February 24, 2023 |
| &nbsp;&nbsp;**Original issue date (settlement date):** | March 1, 2023 | March 1, 2023 | March 1, 2023 |
| &nbsp;&nbsp;**Maturity date:** | February 27, 2025, subject to postponement in the event of certain market disruption events and as described under "General Terms of Notes — Postponement of a Payment Date in the accompanying product supplement | February 27, 2025, subject to postponement in the event of certain market disruption events and as described under "General Terms of Notes — Postponement of a Payment Date in the accompanying product supplement | February 27, 2025, subject to postponement in the event of certain market disruption events and as described under "General Terms of Notes — Postponement of a Payment Date in the accompanying product supplement |
| &nbsp;&nbsp;**CUSIP/ISIN:** | 48133UGM8 / US48133UGM80 | 48133UGM8 / US48133UGM80 | 48133UGM8 / US48133UGM80 |
| &nbsp;&nbsp;**Listing:** | The securities will not be listed on any securities exchange. | The securities will not be listed on any securities exchange. | The securities will not be listed on any securities exchange. |
| &nbsp;&nbsp;**Agent:** | J.P. Morgan Securities LLC ("JPMS") | J.P. Morgan Securities LLC ("JPMS") | J.P. Morgan Securities LLC ("JPMS") |
| &nbsp;&nbsp;**Commissions and issue price:** | **Price to public<sup>(1)</sup>** | **Fees and commissions** | **Proceeds to issuer** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Per security** | $1000.00 | $15.00 <sup>(2)</sup> | $980.00 |
|  |  | $5.00 <sup>(3)</sup> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $11370000.00 | $227400.00 | $11142600.00 |

---

&nbsp;&nbsp;&nbsp;&nbsp;*(1)* *See "Additional Information about the Securities — Supplemental use of proceeds and hedging" in this document for information about the components of the price to public of the securities.* 

&nbsp;&nbsp;&nbsp;&nbsp;*(2)* *JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $15.00 per $1,000 stated principal amount security it receives from us to Morgan Stanley Smith Barney LLC ("Morgan Stanley Wealth Management"). See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement* 

&nbsp;&nbsp;&nbsp;&nbsp;*(3)* *Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $5.00 for each $1,000 stated principal amount security* 

**The estimated value of the securities on the pricing date was $965.00 per $1,000 stated principal amount security.** See "Additional Information about the Securities — The estimated value of the securities" in this document for additional information.

**Investing in the securities involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, "Risk Factors" beginning on page PS-12 of the accompanying product supplement, "Risk Factors" beginning on page US-3 of the accompanying underlying supplement and "Risk Factors" beginning on page 7 of this document.**

Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this document or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.

*The securities are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.*

**You should read this document together with the related product supplement, underlying supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see "Additional Information about the Securities" at the end of this document.**

Product supplement no. MS-1-II dated November 4, 2020: <u>[http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf)</u> 

Underlying supplement no. 1-II dated November 4, 2020: <u>[http://www.sec.gov/Archives/edgar/data/19617/000095010320021471/crt_dp139381-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320021471/crt_dp139381-424b2.pdf)</u>

Prospectus supplement and prospectus, each dated April 8, 2020: [http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf)

 ****

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Investment Summary

The Contingent Income Callable Securities due February 27, 2025 Based on the Value of the S&P 500<sup>®</sup> Index, which we refer to as the securities, provide an opportunity for investors to earn a contingent quarterly payment, which is an amount equal to $24.00 (2.40% of the stated principal amount) per security, with respect to each quarterly determination date on which the closing level is greater than or equal to 80% of the initial index value, which we refer to as the downside threshold level. The contingent quarterly payment, if any, will be payable quarterly on the contingent payment date immediately following the related determination date. However, if the closing level of the underlying index is less than the downside threshold level on any determination date, investors will receive no contingent quarterly payment for the related quarterly period. It is possible that the closing level of the underlying index could be below the downside threshold level on most or all of the determination dates so that you will receive few or no contingent quarterly payments during the term of the securities. We refer to these payments as contingent, because there is no guarantee that you will receive a payment on any contingent payment date. Even if the underlying index was at or above the downside threshold level on some quarterly determination dates, the underlying index may fluctuate below the downside threshold level on others.

In addition, **we will have the right to redeem the securities at our discretion** on any contingent payment date (other than the final contingent payment date) for the early redemption payment equal to the stated principal amount *plus* any contingent quarterly payment with respect to the related determination date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. If the securities have not previously been redeemed and the final index value is greater than or equal to the downside threshold level, the payment at maturity will be the sum of the stated principal amount and the contingent quarterly payment with respect to the final determination date. However, if the securities have not previously been redeemed and the final index value is less than the downside threshold level, investors will be exposed to the decline in the closing level of the underlying index, as compared to the initial index value, on a 1-to-1 basis. Under these circumstances, the payment at maturity will be (i) the stated principal amount *times* (ii) the index performance factor, which will be less than 80% of the stated principal amount of the securities and could be zero. Investors in the securities must be willing to accept the risk of losing their entire principal and also the risk of receiving few or no contingent quarterly payments over the term of the securities. In addition, investors will not participate in any appreciation of the underlying index.

Supplemental Terms of the Securities

For purposes of the accompanying product supplement, the underlying index is an "Index."

February 2023 Page 2

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Key Investment Rationale

The securities do not provide for the regular payment of interest. Instead, the securities offer investors an opportunity to earn a contingent quarterly payment equal to 2.40% of the stated principal amount with respect to each determination date on which the closing level of the underlying index is greater than or equal to 80% of the initial index value, which we refer to as the downside threshold level. The securities may be redeemed prior to maturity for the stated principal amount per security *plus* any applicable contingent quarterly payment, and the payment at maturity will vary depending on the final index value, as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Scenario 1** | **On any contingent payment date (other than the final contingent payment date), we elect to redeem the securities.**<br> ▪ The securities will be redeemed for (i) the stated principal amount *plus* (ii) any contingent quarterly payment with respect to the related determination date.<br> ▪ Investors will not participate in any appreciation of the underlying index from the initial index value.<br> Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. It is more likely that we will redeem the securities when it would otherwise be advantageous for you to continue to hold the securities. As such, we will be more likely to redeem the securities when the closing level of the underlying index on the determination dates is at or above the downside threshold level, which would otherwise result in an amount of interest payable on the securities that is greater than instruments issued by us of a comparable maturity and credit rating trading in the market. In other words, we will be more likely to redeem the securities when the securities are paying above-market interest.<br> If the securities are redeemed prior to maturity, you will receive no more contingent quarterly payments and may be forced to reinvest in a lower interest rate environment. Under these circumstances, you may not be able to reinvest the proceeds from an investment in the securities at a comparable return for a similar level of risk. On the other hand, we will be less likely to exercise our redemption right when the closing level of the underlying index on the determination dates is below the downside threshold level, such that you will receive no contingent quarterly payments and/or that you will suffer a significant loss on your investment in the securities at maturity. Therefore, if we do not exercise our redemption right, it is more likely that you will receive few or no contingent quarterly payments and that you will suffer a significant loss on your investment at maturity. |
| &nbsp;&nbsp;**Scenario 2** | **The securities are not redeemed prior to maturity, and the final index value is *greater than or equal to* the downside threshold level.**<br> ▪ The payment due at maturity will be (i) the stated principal amount *plus* (ii) the contingent quarterly payment with respect to the final determination date.<br> ▪ Investors will not participate in any appreciation of the underlying index from the initial index value. |
| &nbsp;&nbsp;**Scenario 3** | **The securities are not redeemed prior to maturity, and the final index value is *less than* the downside threshold level.**<br> ▪ The payment due at maturity will be (i) the stated principal amount *times* (ii) the index performance factor.<br> ▪ **Investors will lose some, and may lose all, of their principal in this scenario.** |

---

February 2023 Page 3

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

How the Securities Work

The following diagrams illustrate the potential outcomes for the securities depending on (1) the closing level of the underlying index, (2) the final index value and (3) whether we exercise our option to redeem the securities.

**Diagram #1: Determination Dates (Other Than the Final Determination Date)**

![](image_001.jpg)

**Diagram #2: Payment at Maturity if No Early Redemption Occurs**

![](image_002.jpg)

*For more information about payments on the securities in different hypothetical scenarios, see "Hypothetical Examples" starting on page 5.*

 

February 2023 Page 4

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Hypothetical Examples

The below examples are based on the following terms:

---

| | |
|:---|:---|
| &nbsp;&nbsp;Stated principal amount: | &nbsp;&nbsp;$1,000 per security |
| &nbsp;&nbsp;Hypothetical initial index value: | &nbsp;&nbsp;100.00 |
| &nbsp;&nbsp;Hypothetical downside threshold level: | &nbsp;&nbsp;80.00, which is 80% of the hypothetical initial index value |
| &nbsp;&nbsp;Contingent quarterly payment: | &nbsp;&nbsp;$24.00 (2.40% of the stated principal amount) per security |

---

The hypothetical initial index value of 100.00 has been chosen for illustrative purposes only and does not represent the actual initial index value. The actual initial index value is the closing level of the underlying index on the pricing date and is specified on the cover of this pricing supplement. For historical data regarding the actual closing levels of the underlying index, please see the historical information set forth under "S&P 500<sup>®</sup> Index Overview" in this pricing supplement.

In Examples 1 and 2, the closing level of the underlying index fluctuates over the term of the securities and we elect to call the securities on one of the contingent payment dates (other than the final contingent payment date). In Examples 3 and 4, the securities are not redeemed prior to, and remain outstanding until, maturity. Any redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Example 1** | &nbsp;&nbsp;**Example 1** | &nbsp;&nbsp;**Example 1** | &nbsp;&nbsp;**Example 2** | &nbsp;&nbsp;**Example 2** | &nbsp;&nbsp;**Example 2** |
| &nbsp;&nbsp;**Determination<br> Dates** | &nbsp;&nbsp;Hypothetical <br> Closing Level | &nbsp;&nbsp;Contingent<br> Quarterly<br> Payment | &nbsp;&nbsp;Early<br> Redemption<br> Payment\* | &nbsp;&nbsp;Hypothetical<br> Closing Level | &nbsp;&nbsp;Contingent<br> Quarterly<br> Payment | &nbsp;&nbsp;Early<br> Redemption<br> Payment\* |
| &nbsp;&nbsp;**#1** | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;85.00 | &nbsp;&nbsp;$24.00 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#2** | &nbsp;&nbsp;125.00 | &nbsp;&nbsp;—\* | &nbsp;&nbsp;$1024.00 | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#3** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;45.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#4** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#5** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;85.00 | &nbsp;&nbsp;$24.00 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#6** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;90.00 | &nbsp;&nbsp;$24.00 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#7** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;55.00 | &nbsp;&nbsp;—\* | &nbsp;&nbsp;$1000.00 |
| &nbsp;&nbsp;**Final<br> Determination<br> Date** | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A |

---

\* The early redemption payment includes any unpaid contingent quarterly payment with respect to the related determination date.

▪ In **Example 1**, we elect to redeem the securities on the second contingent payment date. As the closing level on each of the
first determination date is less than the downside threshold level, no contingent quarterly payment was made with respect to that date.
As the closing level on the second determination date is greater than the downside threshold level, the early redemption payment you receive
on the second contingent payment date includes the contingent quarterly payment due with respect to that determination date, and the early
redemption payment is calculated as follows:

stated principal amount + contingent quarterly payment = $1,000 + $24.00 = $1,024.00

*In this example, the optional early redemption feature limits the term of your investment to approximately 6 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent quarterly payments. Further, although the underlying index has appreciated by 25% from its initial index value on the second determination date, you only receive $1,024.00 per security upon redemption and do not benefit from this appreciation.*

▪ In **Example 2**, we elect to redeem the securities on the 7<sup>th</sup> contingent payment date. As the closing level of the
underlying index on each of the first, fifth, and sixth determination dates is greater than the downside threshold level, you receive
the contingent quarterly payment of $24.00 with respect to each of those determination dates. However, because the closing level of the
underlying index is below the downside threshold level on the 7<sup>th</sup> determination date, the early redemption payment you receive
on the 7<sup>th</sup> contingent payment date does not include any contingent quarterly payment with respect to that determination date,
and the early redemption payment is equal to the stated principal amount of $1,000.

February 2023 Page 5

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

*In this example, the optional early redemption feature limits the term of your investment to approximately 21 months and you may not be able to reinvest at comparable terms or returns. If the securities are redeemed early, you will stop receiving contingent quarterly payments. The total payments on the securities will amount to $1,072.00 per security.*

 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Example 3** | &nbsp;&nbsp;**Example 3** | &nbsp;&nbsp;**Example 3** | &nbsp;&nbsp;**Example 4** | &nbsp;&nbsp;**Example 4** | &nbsp;&nbsp;**Example 4** |
| &nbsp;&nbsp;**Determination<br> Dates** | &nbsp;&nbsp;Hypothetical<br> Closing Level | &nbsp;&nbsp;Contingent<br> Quarterly<br> Payment | &nbsp;&nbsp;Early<br> Redemption<br> Payment | &nbsp;&nbsp;Hypothetical<br> Closing Level | &nbsp;&nbsp;Contingent<br> Quarterly<br> Payment | &nbsp;&nbsp;Early<br> Redemption<br> Payment |
| &nbsp;&nbsp;**#1** | &nbsp;&nbsp;45.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;35.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#2** | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#3** | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;45.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#4** | &nbsp;&nbsp;45.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#5** | &nbsp;&nbsp;35.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;60.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#6** | &nbsp;&nbsp;40.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**#7** | &nbsp;&nbsp;45.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;50.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**Final<br> Determination <br> Date** | &nbsp;&nbsp;40.00 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;N/A | &nbsp;&nbsp;80.00 | &nbsp;&nbsp;—\* | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**Payment at <br> Maturity** | &nbsp;&nbsp;**$400.00** | &nbsp;&nbsp;**$400.00** | &nbsp;&nbsp;**$400.00** | &nbsp;&nbsp;**$1024.00** | &nbsp;&nbsp;**$1024.00** | &nbsp;&nbsp;**$1024.00** |

---

\* The final contingent quarterly payment, if any, will be paid at maturity.

Examples 3 and 4 illustrate the payment at maturity per security based on the final index value.

▪ In **Example 3**, the securities are not redeemed prior to maturity and the closing level of the underlying index remains below
the downside threshold level throughout the term of the securities. As a result, you do not receive any contingent quarterly payment during
the term of the securities and, at maturity, you are fully exposed to the decline in the closing level of the underlying index. As the
final index value is less than the downside threshold level, you receive at maturity (i) the stated principal amount *times* (ii)
the index performance factor, calculated as follows:

$1,000 × 40.00 / 100.00 = $400.00

*In this example, the amount you receive at maturity is significantly less than the stated principal amount.*

▪ In **Example 4**, the securities are not redeemed prior to maturity and the closing level of the underlying index decreases to
a final index value of 80.00. Although the final index value is less than the initial index value, because the final index value is still
not less than the downside threshold level, you receive the stated principal amount *plus* a contingent quarterly payment with respect
to the final determination date. Your payment at maturity is calculated as follows:

$1,000 + $24.00 = $1,024.00

*In this example, although the final index value represents a 20% decline from the initial index value, you receive the stated principal amount per security plus the contingent quarterly payment, equal to a total payment of $1,024.00 per security at maturity.*

The hypothetical returns and hypothetical payments on the securities shown above apply **only if you hold the securities for their entire term or until early redemption.** These hypotheticals do not reflect fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower.

February 2023 Page 6

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Risk Factors

*The following is a non-exhaustive list of certain key risk factors for investors in the securities. For further discussion of these and other risks, you should read the sections entitled "Risk Factors" of the accompanying prospectus supplement, the accompanying product supplement and the accompanying underlying supplement. We urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.*

Risks Relating to the Securities Generally

▪ **The securities do not guarantee the return of any principal and your investment in the securities may result in a loss.** The
terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the return of any of the
principal amount at maturity. Instead, if the securities have not been redeemed prior to maturity and if the final index value is less
than the downside threshold level, you will be exposed to the decline in the closing level of the underlying index, as compared to the
initial index value, on a 1-to-1 basis and you will receive for each security that you hold at maturity a cash payment equal to the stated
principal amount *times* the index performance factor. In this case, your payment at maturity will be less than 80% of the stated
principal amount and could be zero.

▪ **You will not receive any contingent quarterly payment for any quarterly period if the closing level of the underlying index on the relevant determination date is less than the downside threshold level.** The terms of the securities differ from those of ordinary
debt securities in that the securities do not guarantee the payment of regular interest. Instead, a contingent quarterly payment will
be made with respect to a quarterly period only if the closing level of the underlying index on the relevant determination date is greater
than or equal to the downside threshold level. If the closing level of the underlying index remains below the downside threshold level
on any determination date, you will not receive a contingent quarterly payment for the related quarterly period. It
is possible that the closing level of the underlying index could be below the downside threshold level
on most or all of the determination dates so that you will receive few
or no contingent quarterly payments. If you do not earn sufficient contingent quarterly payments over the term of the securities, the
overall return on the securities may be less than the amount that would be paid on one of our conventional debt securities of comparable
maturity.

▪ **The contingent quarterly payment is based solely on the closing levels of the underlying index on the specified determination dates .** Whether the contingent quarterly payment will be made with respect to a determination date will be based on the closing level
of the underlying index on that determination date. As a result, you will not know whether you will receive the contingent quarterly payment
until the related determination date. Moreover, because the contingent quarterly payment is based solely on the closing level of the underlying
index on a specific determination date, if that closing level of the underlying index is less than the downside threshold level, you will
not receive any contingent quarterly payment with respect to that determination date, even if the closing level of the underlying index
was higher on other days during the term of the securities.

▪ **The securities are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co., and any actual or anticipated changes to our or JPMorgan Chase & Co.'s credit ratings or credit spreads may adversely affect the market value of the securities.** Investors are dependent on our and JPMorgan Chase & Co.'s
ability to pay all amounts due on the securities. Any actual or anticipated decline in our or JPMorgan Chase & Co.'s credit
ratings or increase in our or JPMorgan Chase & Co.'s credit spreads determined by the market for taking that credit risk is
likely to adversely affect the market value of the securities. If we and JPMorgan Chase & Co. were to default on our payment obligations,
you may not receive any amounts owed to you under the securities and you could lose your entire investment.

▪ **As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets.** As a finance subsidiary of
JPMorgan Chase & Co., we have no independent operations beyond the issuance and administration of our securities. Aside from the initial
capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of our affiliates to make payments
under loans made by us or other intercompany agreements. As a result, we are dependent upon payments from our affiliates to meet our obligations
under the securities. If these affiliates do not make payments to us and we fail to make payments on the securities, you may have to seek
payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank *pari passu* with all other unsecured
and unsubordinated obligations of JPMorgan Chase & Co.

▪ **Investors will not participate in any appreciation of the underlying index.** Investors will not participate in any appreciation of the underlying index from the initial index value,
and the return on the securities will be limited to the contingent quarterly payment that is paid with respect to each determination date
on which the closing level of the underlying index is greater than or equal to the downside threshold level.

February 2023 Page 7

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

▪ **Early redemption risk.** The term of your investment in the securities
may be limited to as short as approximately three months by the optional early redemption feature of the securities. Any early redemption
of the securities will be at our discretion and will not automatically occur based on the performance of the underlying index. It is more
likely that we will redeem the securities when it would otherwise be advantageous for you to continue to hold the securities. As such,
we will be more likely to redeem the securities when the closing level of the underlying index on the determination dates is at or above
the downside threshold level, which would otherwise potentially result in an amount of interest payable on the securities that is greater
than instruments issued by us of a comparable maturity and credit rating trading in the market. In other words, we will be more likely
to redeem the securities when the securities are paying above-market interest.

If the securities are redeemed prior to maturity, you will receive no more contingent quarterly payments and may be forced to reinvest in a lower interest rate environment. Under these circumstances, you may not be able to reinvest the proceeds from an investment in the securities at a comparable return for a similar level of risk. On the other hand, we will be less likely to exercise our redemption right when the closing level of the underlying index on the determination dates is below the downside threshold level, such that you will receive no contingent quarterly payments and/or that you might suffer a significant loss on your investment in the securities at maturity. Therefore, if we do not exercise our redemption right, it is more likely that you will receive few or no contingent quarterly payments and that you will suffer a significant loss on your investment at maturity.

▪ **Secondary trading may be limited.** Th e
securities will not be listed on a securities exchange. There may be little or no secondary market for the securities. Even if there is
a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily .
JPMS may act as a market maker for the securities, but is not required to do so. Because we do not expect that other market makers
will participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities
is likely to depend on the price, if any, at which JPMS is willing to buy the securities. If at any time JPMS or another agent does not act as a market maker, it is likely that there would be little or no secondary market for the securities.

▪ **The U.S. federal income tax consequences of an investment in the securities are uncertain.** There is no direct legal authority
as to the proper U.S. federal income tax treatment of the securities, and we do not intend to request a ruling from the IRS. The IRS might
not accept, and a court might not uphold, the treatment of the securities as prepaid forward contracts with associated contingent coupons,
as described in "Additional Information about the Securities — Additional Provisions — Tax considerations" in
this document and in "Material U.S. Federal Income Tax Consequences" in the accompanying product supplement. If the IRS were
successful in asserting an alternative treatment for the securities, the timing and character of any income or loss on the securities
could be materially affected. Although the U.S. federal income tax treatment of contingent quarterly payments (including any contingent
quarterly payments paid in connection with an early redemption or at maturity) is uncertain, in determining our reporting responsibilities
we intend (in the absence of an administrative determination or judicial ruling to the contrary) to treat any contingent quarterly payments
as ordinary income. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment
of "prepaid forward contracts" and similar instruments. The notice focuses in particular on whether to require investors in
these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including
the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property
to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury
regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment
in the securities, possibly with retroactive effect. You should review carefully the section entitled "Material U.S. Federal Income
Tax Consequences" in the accompanying product supplement and consult your tax adviser regarding the U.S. federal income tax consequences
of an investment in the securities, including possible alternative treatments and the issues presented by this notice.

*Non-U.S. Holders — Tax Considerations*. The U.S. federal income tax treatment of contingent quarterly payments is uncertain, and although we believe it is reasonable to take a position that contingent quarterly payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), it is expected that withholding agents will (and we, if we are the withholding agent, intend to) withhold on any contingent quarterly payment paid to a Non-U.S. Holder generally at a rate of 30% or at a reduced rate specified by an applicable income tax treaty under an "other income" or similar provision. We will not be required to pay any additional amounts with respect to amounts withheld. In order to claim an exemption from, or a reduction in, the 30% withholding tax, a Non-U.S. Holder of the securities must comply with certification requirements to establish that it is not a U.S. person and is eligible for such an exemption or reduction under an applicable tax treaty. If you are a Non-U.S. Holder, you should consult your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any withholding tax and the certification requirement described above.

February 2023 Page 8

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Risks Relating to Conflicts of Interest

▪ **Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of the securities and other affiliates of the issuer may be different from those of investors.** We
and our affiliates play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and
as an agent of the offering of the securities, hedging our obligations under the securities and making the assumptions used to determine
the pricing of the securities and the estimated value of the securities, which we refer to as the estimated value of the securities. In
performing these duties, our and JPMorgan Chase & Co.'s economic interests and the economic interests of the calculation agent
and other affiliates of ours are potentially adverse to your interests as an investor in the securities. The calculation agent has determined
the initial index value, and the downside threshold level and will determine the final index value and whether the closing level of the
underlying index on any determination date is below the downside threshold level. Determinations made by the calculation agent, including
with respect to the occurrence or non-occurrence of market disruption events, may affect the payment to you at maturity or upon an early
redemption.

In addition, our and JPMorgan Chase & Co.'s business activities, including hedging and trading activities, could cause our and JPMorgan Chase & Co.'s economic interests to be adverse to yours and could adversely affect any payment on the securities and the value of the securities. It is possible that hedging or trading activities of ours or our affiliates in connection with the securities could result in substantial returns for us or our affiliates while the value of the securities declines. Please refer to "Risk Factors — Risks Relating to Conflicts of Interest" in the accompanying product supplement for additional information about these risks.

▪ **Hedging and trading activities by the issuer and its affiliates could potentially affect the value of the securities .** The hedging or trading activities of the issuer's affiliates and of any other hedging counterparty with respect to the securities
on or prior to the pricing date and prior to maturity could have adversely affected, and may continue to adversely affect the value of
the underlying index. Any of these hedging or trading activities on or prior to the pricing date could have affected the initial
index value and, as a result, the downside threshold level, which is the value at or above which the underlying index must close on each
determination date in order for you to earn a contingent quarterly payment or, if the securities are not redeemed prior to maturity, in
order for you to avoid being exposed to the negative performance of the underlying index at maturity. Additionally, these hedging or trading
activities during the term of the securities could
potentially affect the closing level of the underlying index on the determination dates and, accordingly, whether investors will receive
one or more contingent quarterly payments and, if the securities are not redeemed prior to maturity, the payment to you at maturity. It
is possible that these hedging or trading activities could result in substantial returns for us or our affiliates while the value of the
securities declines.

Risks Relating to the Estimated Value and Secondary Market Prices of the Securities

▪ **The estimated value of the securities is lower than the original issue price (price to public) of the securities.** The estimated value of the securities is only an estimate
determined by reference to several factors. The original issue price of the securities exceeds the estimated value of the securities because
costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These
costs include the selling commissions, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming
risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities.
See "Additional Information about the Securities — The estimated value of the securities" in this document.

▪ **The estimated value of the securities does not represent future values of the securities and may differ from others' estimates. The estimated value of the securities is determined by reference to internal pricing models of our affiliates.** This estimated value of the securities is based on market conditions
and other relevant factors existing at the time of pricing and assumptions about market parameters, which can include volatility, dividend
rates, interest rates and other factors. Different pricing models and assumptions could provide valuations for the securities that are
greater than or less than the estimated value of the securities. In addition, market conditions and other relevant factors in the future
may change, and any assumptions may prove to be incorrect. On future dates, the value of the securities could change significantly based
on, among other things, changes in market conditions, our or JPMorgan Chase & Co.'s creditworthiness, interest rate movements
and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy securities from you in secondary
market transactions. See "Additional Information about the Securities — The estimated value of the securities" in this
document.

▪ **The estimated value of the securities is derived by reference to an internal funding rate.** The internal funding rate used in the determination of the estimated value of the
securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan
Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates' view of the funding
value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to

February 2023 Page 9

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. See "Additional Information about the Securities — The estimated value of the securities" in this document.

▪ **The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than the then-current estimated value of the securities for a limited time period.** We
generally expect that some of the costs included in the original issue price of the securities will be partially paid back to you in connection
with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period. These costs
can include selling commissions, the structuring fee, projected hedging profits, if any, and, in some circumstances, estimated hedging
costs and our internal secondary market funding rates for structured debt issuances. See "Additional Information about the Securities
— Secondary market prices of the securities" in this document for additional information relating to this initial period.
Accordingly, the estimated value of your securities during this initial period may be lower than the value of the securities as published
by JPMS (and which may be shown on your customer account statements).

▪ **Secondary market prices of the securities will likely be lower than the original issue price of the securities.** Any secondary market prices of the securities will likely
be lower than the original issue price of the securities because, among other things, secondary market prices take into account our internal
secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions,
the structuring fee, projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the
securities. As a result, the price, if any, at which JPMS will be willing to buy securities from you in secondary market transactions,
if at all, is likely to be lower than the original issue price. Any sale by you prior to the maturity date could result in a substantial
loss to you. See the immediately following risk factor for information about additional factors that will impact any secondary market
prices of the securities.

The securities are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your securities to maturity. See "— Secondary trading may be limited" below.

▪ **Secondary market prices of the securities will be impacted by many economic and market factors.** The secondary market price of the securities during their term will be
impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the selling commissions,
structuring fee, projected hedging profits, if any, estimated hedging costs and the closing level of the underlying index, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o any actual or potential change in our or JPMorgan Chase & Co.'s creditworthiness or credit spreads;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o customary bid-ask spreads for similarly sized trades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o our internal secondary market funding rates for structured debt issuances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o the actual and expected volatility of the underlying index;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o the time to maturity of the securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o whether the closing level of the underlying index has been, or is expected to be, less than the downside threshold level on any determination
date and whether the final index value is expected to be less than the downside threshold level;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o whether we are expected to exercise our right to redeem the securities early;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o the dividend rates on the equity securities included in the underlying index;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o interest and yield rates in the market generally; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o a variety of other economic, financial, political, regulatory and judicial events.

Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the securities, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the securities, if any, at which JPMS may be willing to purchase your securities in the secondary market.

Risks Relating to the Underlying Index

▪ **JPMorgan Chase & Co. is currently one of the companies that make up the underlying index**. JPMorgan Chase & Co. is currently one of the companies that make up the
underlying index. JPMorgan Chase & Co. will not have any obligation to consider your interests as a holder of the securities in taking
any corporate action that might affect the value of the underlying index or the securities.

February 2023 Page 10

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

▪ **Investing in the securities is not equivalent to investing in the underlying index.** Investing in the securities is not
equivalent to investing in the underlying index or its component stocks. Investors in the securities will not have voting rights
or rights to receive dividends or other distributions or any other rights with respect to the stocks that constitute the underlying index.

▪ **Adjustments to the underlying index could adversely affect the value of the securities.** The underlying index publisher
may discontinue or suspend calculation or publication of the underlying index at any time. In these circumstances, the calculation
agent will have the sole discretion to substitute a successor index that is comparable to the discontinued underlying index and is not
precluded from considering indices that are calculated and published by the calculation agent or any of its affiliates.

▪ **Governmental legislative and regulatory actions, including sanctions, could adversely affect your investment in the securities.** Governmental legislative and regulatory actions, including, without limitation, sanctions-related actions by the U.S. or a foreign
government, could prohibit or otherwise restrict persons from holding the securities or the securities included in the underlying index,
or engaging in transactions in them, and any such action could adversely affect the value of the securities or the underlying index. 
These legislative and regulatory actions could result in restrictions on the securities. You may lose a significant portion or all
of your initial investment in the securities if you are forced to divest the securities due to the government mandates, especially if
such divestment must be made at a time when the value of the securities has declined.

February 2023 Page 11

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

S&P 500<sup>®</sup> Index Overview

The S&P 500<sup>®</sup> Index, which is calculated, maintained and published by S&P Dow Jones Indices LLC, consists of stocks of 500 companies selected to provide a performance benchmark for the U.S. equity markets. For additional information about the S&P 500<sup>®</sup> Index, see "Equity Index Descriptions — The S&P U.S. Indices" in the accompanying underlying supplement.

Information as of market close on February 24, 2023:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Bloomberg Ticker Symbol:** | &nbsp;&nbsp;SPX | &nbsp;&nbsp;**52 Week High (on 3/29/2022):** | &nbsp;&nbsp;4631.60 |
| &nbsp;&nbsp;**Current Closing Level:** | &nbsp;&nbsp;3970.04 | &nbsp;&nbsp;**52 Week Low (on 10/12/2022):** | &nbsp;&nbsp;3577.03 |
| &nbsp;&nbsp;**52 Weeks Ago (on 2/24/2022):** | &nbsp;&nbsp;4288.70 |  |  |

---

The following table sets forth the published high and low closing levels, as well as end-of-quarter closing levels, of the underlying index for each quarter in the period from January 1, 2018 through February 24, 2023. The closing level of the underlying index on February 24, 2023 was 3,970.04. The associated graph shows the closing levels of the underlying index for each day in the same period. We obtained the closing level information above and in the table and graph below from the Bloomberg Professional<sup>®</sup> service ("Bloomberg"), without independent verification.

The historical closing levels of the underlying index should not be taken as an indication of future performance, and no assurance can be given as to the closing level of the underlying index at any time, including on the determination dates. The payment of dividends on the stocks that constitute the underlying index are not reflected in its closing level and, therefore, have no effect on the calculation of any payment on the securities.

---

| | | | |
|:---|:---|:---|:---|
| **S&P 500<sup>®</sup> Index** | **High** | **Low** | **Period End** |
| **2018** |  |  |  |
| First Quarter | &nbsp;&nbsp;2872.87 | &nbsp;&nbsp;2581.00 | &nbsp;&nbsp;2640.87 |
| Second Quarter | &nbsp;&nbsp;2786.85 | &nbsp;&nbsp;2581.88 | &nbsp;&nbsp;2718.37 |
| Third Quarter | &nbsp;&nbsp;2930.75 | &nbsp;&nbsp;2713.22 | &nbsp;&nbsp;2913.98 |
| Fourth Quarter | &nbsp;&nbsp;2925.51 | &nbsp;&nbsp;2351.10 | &nbsp;&nbsp;2506.85 |
| **2019** |  |  |  |
| First Quarter | &nbsp;&nbsp;2854.88 | &nbsp;&nbsp;2447.89 | &nbsp;&nbsp;2834.40 |
| Second Quarter | &nbsp;&nbsp;2954.18 | &nbsp;&nbsp;2744.45 | &nbsp;&nbsp;2941.76 |
| Third Quarter | &nbsp;&nbsp;3025.86 | &nbsp;&nbsp;2840.60 | &nbsp;&nbsp;2976.74 |
| Fourth Quarter | &nbsp;&nbsp;3240.02 | &nbsp;&nbsp;2887.61 | &nbsp;&nbsp;3230.78 |
| **2020** |  |  |  |
| First Quarter | &nbsp;&nbsp;3386.15 | &nbsp;&nbsp;2237.40 | &nbsp;&nbsp;2584.59 |
| Second Quarter | &nbsp;&nbsp;3232.39 | &nbsp;&nbsp;2470.50 | &nbsp;&nbsp;3100.29 |
| Third Quarter | &nbsp;&nbsp;3580.84 | &nbsp;&nbsp;3115.86 | &nbsp;&nbsp;3363.00 |
| Fourth Quarter | &nbsp;&nbsp;3756.07 | &nbsp;&nbsp;3269.96 | &nbsp;&nbsp;3756.07 |
| **2021** |  |  |  |
| First Quarter | &nbsp;&nbsp;3974.54 | &nbsp;&nbsp;3700.65 | &nbsp;&nbsp;3972.89 |
| Second Quarter | &nbsp;&nbsp;4297.50 | &nbsp;&nbsp;4019.87 | &nbsp;&nbsp;4297.50 |
| Third Quarter | &nbsp;&nbsp;4536.95 | &nbsp;&nbsp;4258.49 | &nbsp;&nbsp;4307.54 |
| Fourth Quarter | &nbsp;&nbsp;4793.06 | &nbsp;&nbsp;4300.46 | &nbsp;&nbsp;4766.18 |
| **2022** |  |  |  |
| First Quarter | &nbsp;&nbsp;4796.56 | &nbsp;&nbsp;4170.70 | &nbsp;&nbsp;4530.41 |
| Second Quarter | &nbsp;&nbsp;4582.64 | &nbsp;&nbsp;3666.77 | &nbsp;&nbsp;3785.38 |
| Third Quarter | &nbsp;&nbsp;4305.20 | &nbsp;&nbsp;3585.62 | &nbsp;&nbsp;3585.62 |
| Fourth Quarter | &nbsp;&nbsp;4080.11 | &nbsp;&nbsp;3577.03 | &nbsp;&nbsp;3839.50 |
| **2023** |  |  |  |
| First Quarter (through February 24, 2023) | &nbsp;&nbsp;4179.76 | &nbsp;&nbsp;3808.10 | &nbsp;&nbsp;3970.04 |

---

February 2023 Page 12

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

---

| |
|:---|
| &nbsp;&nbsp;**S&P 500<sup>®</sup> Index Historical Performance – Daily Closing Levels\*<br> January 2, 2018 to February 24, 2023** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*The dotted line in the graph indicates the downside threshold level, equal to 80% of the initial index value. |

---

**License Agreement.** "Standard & Poor's<sup>®</sup>," "S&P<sup>®</sup>," "S&P 500<sup>®</sup>" and "Standard & Poor's 500" are trademarks of Standard & Poor's Financial Services LLC and have been licensed for use by JPMorgan Chase & Co. and its affiliates, including JPMorgan Financial. See "Equity Index Descriptions — The S&P U.S. Indices — License Agreement" in the accompanying underlying supplement.

February 2023 Page 13

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

Additional Information about the Securities

Please read this information in conjunction with the summary terms on the front cover of this document.

---

| | |
|:---|:---|
| **Additional Provisions** |  |
| &nbsp;&nbsp;**Record date:** | &nbsp;&nbsp;The record date for each contingent payment date is the date one business day prior to that contingent payment date. |
| &nbsp;&nbsp;**Postponement of maturity date:** | &nbsp;&nbsp;If the scheduled maturity date is not a business day, then the maturity date will be the following business day. If the scheduled final determination date is not a trading day or if a market disruption event occurs on that day so that the final determination date is postponed and falls less than three business days prior to the scheduled maturity date, the maturity date of the securities will be postponed to the third business day following that final determination date as postponed. |
| &nbsp;&nbsp;**Minimum ticketing size:** | &nbsp;&nbsp;$1,000 / 1 security |
| &nbsp;&nbsp;**Trustee:** | Deutsche Bank Trust Company Americas (formerly Bankers Trust Company) |
| &nbsp;&nbsp;**Calculation agent:** | JPMS |
| &nbsp;&nbsp;**The estimated value of the securities:** | The estimated value of the securities set forth on the cover of this document is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the securities, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the securities. The estimated value of the securities does not represent a minimum price at which JPMS would be willing to buy your securities in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated value of the securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates' view of the funding value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. For additional information, see "Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is derived by reference to an internal funding rate" in this document. The value of the derivative or derivatives underlying the economic terms of the securities is derived from internal pricing models of our affiliates. These models are dependent on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments. Accordingly, the estimated value of the securities on the pricing date is based on market conditions and other relevant factors and assumptions existing at that time. See "Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities does not represent future values of the securities and may differ from others' estimates" in this document.<br> The estimated value of the securities is lower than the original issue price of the securities because costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities. Because hedging our obligations entails risk and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. A portion of the profits, if any, realized in hedging our obligations under the securities may be allowed to other affiliated or unaffiliated dealers, and we or one or more of our affiliates will retain any remaining hedging profits. See "Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is lower than the original issue price (price to public) of the securities" in this document. |
| &nbsp;&nbsp;**Secondary market prices of the securities:** | For information about factors that will impact any secondary market prices of the securities, see "Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — Secondary market prices of the securities will be impacted by many economic and market factors" in this document. In addition, we generally expect that some of the costs included in the original issue price of the securities will be partially paid back to you in connection with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period that is intended to be the shorter of two years and one-half of the stated term of the securities. The length of any such initial period reflects the structure of the securities, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs of hedging the securities and when these costs are incurred, as determined by our affiliates. See "Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than |

---

February 2023 Page 14

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;the then-current estimated value of the securities for a limited time period." |
|  **Tax considerations:**<br>| You should review carefully the section entitled "Material U.S. Federal Income Tax Consequences" in the accompanying product supplement no. MS-1-II. In determining our reporting responsibilities we intend to treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii) any contingent quarterly payments as ordinary income, as described in the section entitled "Material U.S. Federal Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward Contracts with Associated Contingent Coupons" in the accompanying product supplement. Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel, we believe that this is a reasonable treatment, but that there are other reasonable treatments that the IRS or a court may adopt, in which case the timing and character of any income or loss on the securities could be materially affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of "prepaid forward contracts" and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the securities, possibly with retroactive effect. The discussions above and in the accompanying product supplement do not address the consequences to taxpayers subject to special tax accounting rules under Section 451(b) of the Code. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by the notice described above.<br> *Non-U.S. Holders — Tax Considerations.* The U.S. federal income tax treatment of contingent quarterly payments is uncertain, and although we believe it is reasonable to take a position that contingent quarterly payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), it is expected that withholding agents will (and we, if we are the withholding agent, intend to) withhold on any contingent quarterly payment paid to a Non-U.S. Holder generally at a rate of 30% or at a reduced rate specified by an applicable income tax treaty under an "other income" or similar provision. We will not be required to pay any additional amounts with respect to amounts withheld. In order to claim an exemption from, or a reduction in, the 30% withholding tax, a Non-U.S. Holder of the securities must comply with certification requirements to establish that it is not a U.S. person and is eligible for such an exemption or reduction under an applicable tax treaty. If you are a Non-U.S. Holder, you should consult your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any withholding tax and the certification requirement described above.<br> Section 871(m) of the Code and Treasury regulations promulgated thereunder ("Section 871(m)") generally impose a 30% withholding tax (unless an income tax treaty applies) on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. Section 871(m) provides certain exceptions to this withholding regime, including for instruments linked to certain broad-based indices that meet requirements set forth in the applicable Treasury regulations. Additionally, a recent IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2025 that do not have a delta of one with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an "Underlying Security"). Based on certain determinations made by us, our special tax counsel is of the opinion that Section 871(m) should not apply to the securities with regard to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. You should consult your tax adviser regarding the potential application of Section 871(m) to the securities.<br> In the event of any withholding on the securities, we will not be required to pay any additional amounts with respect to amounts so withheld. |
| &nbsp;&nbsp;**Supplemental use of proceeds and hedging:** | The securities are offered to meet investor demand for products that reflect the risk-return profile and market exposure provided by the securities. See "How the Securities Work" and "Hypothetical Examples" in this document for an illustration of the risk-return profile of the securities and "S&P 500<sup>®</sup> Index Overview" in this document for a description of the market exposure provided by the securities.<br> The original issue price of the securities is equal to the estimated value of the securities plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers and the structuring fee, plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities, plus the estimated cost of hedging our obligations under the securities. |
|  **Benefit plan investor considerations:**<br>| See "Benefit Plan Investor Considerations" in the accompanying product supplement. |

---

February 2023 Page 15

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Supplemental plan of distribution:** | Subject to regulatory constraints, JPMS intends to use its reasonable efforts to offer to purchase the securities in the secondary market, but is not required to do so. JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to Morgan Stanley Wealth Management. In addition, Morgan Stanley Wealth Management will receive a structuring fee as set forth on the cover of this document for each security.<br> We or our affiliate may enter into swap agreements or related hedge transactions with one of our other affiliates or unaffiliated counterparties in connection with the sale of the securities and JPMS and/or an affiliate may earn additional income as a result of payments pursuant to the swap or related hedge transactions. See "— Supplemental use of proceeds and hedging" above and "Use of Proceeds and Hedging" in the accompanying product supplement.<br> We expect that delivery of the securities will be made against payment for the securities on or about the original issue date set forth on the front cover of this document, which will be the third business day following the pricing date of the securities (this settlement cycle being referred to as "T+3"). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade securities on any date prior to two business days before delivery will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.<br> Canada<br> The securities may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions ("NI 45-106") or subsection 73.3(1) of the Securities Act (Ontario) (the "OSA"), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations ("NI-33-103").<br> Accordingly, by placing a purchase order for securities, each purchaser of securities in Canada will be deemed to have represented to the issuer, the guarantor and each agent and dealer participating in the sale of the securities that such purchaser:<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· is an "accredited investor" as defined in section 1.1 of NI 45-106 or subsection 73.3(1) of the OSA and is either purchasing the securities as principal for its own account, or is deemed to be purchasing the securities as principal by applicable law;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· is a "permitted client" as defined in section 1.1 of NI 31-103 and, in particular, if the purchaser is an individual, he or she beneficially owns financial assets (as defined in section 1.1 of NI 45-106) having an aggregate realizable value that, before taxes but net of any related liabilities, exceeds CAD$5,000,000;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· is not a company or other entity created or being used solely to purchase or hold securities as an "accredited investor"; and<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· is not an "insider" of the issuer or the guarantor and is not registered as a dealer, adviser or otherwise under the securities laws of any province or territory of Canada.<br> The securities are being distributed in Canada on a private placement basis only and therefore any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. Each of the issuer and the guarantor is not a reporting issuer in any province or territory in Canada and the securities are not listed on any stock exchange in Canada and there is currently no public market for the securities in Canada. Each of the issuer and the guarantor currently has no intention of becoming a reporting issuer in Canada, filing a prospectus with any securities regulatory authority in Canada to qualify the resale of the securities to the public, or listing its securities on any stock exchange in Canada. Canadian purchasers are advised to seek legal advice prior to any resale of the securities.<br> Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this document (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province or territory for particulars of these rights or consult with a legal advisor.<br> The issuer, the guarantor, the agents and the dealers are relying on the statutory exemption contained in section 3A.3 of National Instrument 33-105 Underwriting Conflicts ("NI 33-105"), which provides that the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering are not applicable.<br> By purchasing securities, the purchaser acknowledges that the issuer, the guarantor, the agents and the dealers and their respective agents and advisers may each collect, use and disclose its name, telephone number, address, the number and value of any securities purchased and other specified personally identifiable information (the "personal information"), including the principal amount of securities that it has purchased and whether the purchaser is an "insider" of the issuer or the guarantor or a "registrant" for purposes of meeting legal, regulatory and audit requirements and as otherwise permitted or required by law or regulation. By purchasing securities, the purchaser consents to the |

---

February 2023 Page 16

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

---

| | |
|:---|:---|
|  | foregoing collection, use and disclosure of the personal information pertaining to the purchaser.<br> Furthermore, by purchasing securities, the purchaser acknowledges that the personal information concerning the purchaser (A) will be disclosed to the relevant Canadian securities regulatory authorities and may become available to the public in accordance with the requirements of applicable securities and freedom of information laws and the purchaser consents to the disclosure of the personal information; (B) is being collected indirectly by the applicable Canadian securities regulatory authority under the authority granted to it in securities legislation; and (C) is being collected for the purposes of the administration and enforcement of the applicable Canadian securities legislation. By purchasing securities, the purchaser shall be deemed to have authorized such indirect collection of the personal information by the relevant Canadian securities regulatory authorities.<br> Questions about the indirect collection of personal information should be directed to the securities regulatory authority in the province of the purchaser, using the following contact information: in British Columbia, the British Columbia Securities Commission can be contacted at P.O. Box 10142, Pacific Center, 701 West Georgia Street, Vancouver, British Columbia V7Y 1L2 or at (604) 899-6500 or 1-800-373-6393; in Alberta, the Alberta Securities Commission can be contacted at Suite 600, 250 – 5th Street SW, Calgary, Alberta T2P 0R4 or at (403) 297-6454 or 1-877-355-0585; in Saskatchewan, the Financial and Consumer Affairs Authority of Saskatchewan can be contacted at Suite 601 – 1919 Saskatchewan Drive, Regina, Saskatchewan S4P 4H2 or at (306) 787-5842; in Manitoba, The Manitoba Securities Commission can be contacted at 500 – 400 St. Mary Avenue, Winnipeg, Manitoba R3C 4K5 or at (204) 945-2561 or 1-800-655-5244; in Ontario, the Ontario Securities Commission can be contacted at 20 Queen Street West, 22nd Floor, Toronto, Ontario M5H 3S8 or at (416) 593-8314 or 1-877-785-1555; in Québec, the Autorité des marchés financiers can be contacted at 800, Square Victoria, 22e étage, C.P. 246, Tour de la Bourse, Montréal, Québec H4Z 1G3 or at (514) 395-0337 or 1-877-525-0337; in New Brunswick, the Financial and Consumer Services Commission (New Brunswick) can be contacted at 85 Charlotte Street, Suite 300, Saint John, New Brunswick E2L 2J2 or at (506) 658-3060 or 1-866-933-2222; in Nova Scotia, the Nova Scotia Securities Commission can be contacted at Suite 400, 5251 Duke Street, Duke Tower, P.O. Box 458, Halifax, Nova Scotia B3J 2P8 or at (902) 424-7768; in Prince Edward Island, the Prince Edward Island Securities Office can be contacted at 95 Rochford Street, 4th Floor Shaw Building, P.O. Box 2000, Charlottetown, Prince Edward Island C1A 7N8 or at (902) 368-4569; and in Newfoundland and Labrador, the Director of Securities of the Government of Newfoundland and Labrador's Financial Services Regulation Division can be contacted at P.O. Box 8700, Confederation Building, 2nd Floor, West Block, Prince Philip Drive, St. John's, Newfoundland and Labrador A1B 4J6 or at (709) 729-4189; and (b) has authorized the indirect collection of the personal information by the securities regulatory authority or regulator in the local jurisdiction.<br> The purchaser acknowledges that each of the issuer and the guarantor is an entity formed under the laws of a jurisdiction outside of Canada. Some or all of the managers and officers of the issuer or the guarantor may be located outside Canada and, as a result, it may not be possible for purchasers to effect service of process within Canada upon such entity or such persons. All or a substantial portion of the assets of each of the issuer and the guarantor may be located outside of Canada and, as a result, it may not be possible to satisfy a judgment in Canada against the issuer, the guarantor or their respective directors and officers or to enforce a judgment obtained in Canadian courts against the issuer, the guarantor or such persons outside of Canada. The securities will not be governed by the laws of any province or territory of Canada. Accordingly, it may not be possible to enforce securities in accordance with their terms in a Canadian court.<br> This document does not address the Canadian tax consequences of ownership of securities. Prospective purchasers should consult their own tax advisors with respect to the Canadian and other tax considerations applicable to them. |
| &nbsp;&nbsp;**Supplemental information about the form of the securities:** | &nbsp;&nbsp;The securities will initially be represented by a type of global security that we refer to as a master note. A master note represents multiple securities that may be issued at different times and that may have different terms. The trustee and/or paying agent will, in accordance with instructions from us, make appropriate entries or notations in its records relating to the master note representing the securities to indicate that the master note evidences the securities. |
| &nbsp;&nbsp;**<br> Validity of the securities and the guarantee:** | &nbsp;&nbsp;In the opinion of Davis Polk & Wardwell LLP, as special products counsel to JPMorgan Financial and JPMorgan Chase & Co., when the securities offered by this pricing supplement have been issued by JPMorgan Financial pursuant to the indenture, the trustee and/or paying agent has made, in accordance with the instructions from JPMorgan Financial, the appropriate entries or notations in its records relating to the master global note that represents such securities (the "master note"), and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations of JPMorgan Financial and the related guarantee will constitute a valid and binding obligation of JPMorgan Chase & Co., enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors' rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), *provided* that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on |

---

February 2023 Page 17

JPMorgan Chase Financial Company LLC

Contingent Income Callable Securities due February 27, 2025

**Based on the Value of the S&P 500<sup>®</sup> Index <br> Principal at Risk Securities**

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;the conclusions expressed above or (ii) any provision of the indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of JPMorgan Chase & Co.'s obligation under the related guarantee.<br> This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act.<br> In addition, this opinion is subject to customary assumptions about the trustee's authorization, execution and delivery of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect to the trustee, all as stated in the letter of such counsel dated May 6, 2022, which was filed as an exhibit to a Current Report on Form 8-K by JPMorgan Chase & Co. on May 6, 2022. |
| &nbsp;&nbsp;**Where you can find more information:** | You should read this document together with the accompanying prospectus, as supplemented by the accompanying prospectus supplement, relating to our Series A medium-term notes of which these securities are a part, and the more detailed information contained in the accompanying product supplement and the accompanying underlying supplement.<br> This document, together with the documents listed below, contains the terms of the securities and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, stand-alone fact sheets, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in the "Risk Factors" sections of the accompanying prospectus supplement, the accompanying product supplement and the accompanying underlying supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the securities.<br> You may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):<br> **• Product supplement no. MS-1-II dated November 4, 2020:** <br> <u>[http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320021469/crt_dp139325-424b2.pdf)</u> <br> **• Underlying supplement no. 1-II dated November 4, 2020:**<br> <u>[http://www.sec.gov/Archives/edgar/data/19617/000095010320021471/crt_dp139381-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320021471/crt_dp139381-424b2.pdf)</u><br> **• Prospectus supplement and prospectus, each dated April 8, 2020:**<br> [http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010320007214/crt_dp124361-424b2.pdf)<br> Our Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase & Co.'s CIK is 19617.<br> As used in this document, "we," "us," and "our" refer to JPMorgan Financial. |

---

February 2023 Page 18

## Ex-Filing

**Exhibit 107.1**

The pricing supplement to which this Exhibit is attached is a final prospectus for the related offering(s). The maximum aggregate offering price of the related offering(s) is $11,370,000.